Efficacy and Safety of Ocedurenone: Subgroup Analysis of the BLOCK-CKD Study

CONCLUSIONS: Ocedurenone consistently reduced in SBP in all patient subgroups. Moreover, while small elevations in serum potassium occurred, they were not associated with Ocedurenone or study discontinuation.PMID:37471468 | DOI:10.1093/ajh/hpad066

Source: American Journal of Hypertension - July 20, 2023 Category: Cardiology Authors: G L Bakris Y F Yang J M McCabe J R Liu X J Tan V J Benn B Pitt Source Type: research